Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer

• Main Authors: Lorvidhaya V., Chitapanarux I., Phromratanapongse P., Kamnerdsupaphon P., Tharavichitkul E., Lertsanguansinchai P., Hsieh C., Sukthomya V.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79961108269&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/43266
• Institution: Chiang Mai University

Purpose: The objective of this study is to evaluate the efficacy and safety of capecitabine in cervical cancer patients who have locoregional failure and/or distant metastasis and failed first line therapy. The efficacy of capecitabine is determined by the overall response rate (ORR) according to WH...